Trials / Completed
CompletedNCT06508073
Neural Therapy in Notalgia Paresthetica
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 12 (actual)
- Sponsor
- Sisli Hamidiye Etfal Training and Research Hospital · Academic / Other
- Sex
- All
- Age
- 30 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Patients diagnosed with Notalgia paresthetica and who received neural therapy within the last year were retrospectively screened. In the evaluations before treatment and at the 3rd month after treatment; Numerical rating scale for pain, PainDETECT questionnaire for neuropathic pain, SF-12 for quality of life and 5-D itch scale for itch level were used.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Neural Therapy | The injection was prepared using a solution of lidocaine 2% and saline 0.9%. A 0.4% lidocaine solution was prepared by diluting 1 cc of lidocaine with 4 cc of saline. |
Timeline
- Start date
- 2024-06-26
- Primary completion
- 2024-07-10
- Completion
- 2024-07-10
- First posted
- 2024-07-18
- Last updated
- 2024-07-18
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT06508073. Inclusion in this directory is not an endorsement.